‘The Last of Us’ might be fiction, but fungi are a looming threat
PharmaVoice
MARCH 20, 2023
Fungal infections are a growing challenge for hospitalized patients, and new treatments are badly needed.
March, 2023
122 
Congress Probes PBM Link to Higher Drug Prices
PharmExec
MARCH 7, 2023
Latest investigation signals more scrutiny of pharmacy benefit managers and their role in treatment cost and coverage.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Novo Nordisk to cut insulin prices by up to 75% in 2024
Pharmafile
MARCH 15, 2023
Danish pharmaceutical company Novo Nordisk has announced that it will cut its prices for insulin products by up to 75%, beginning in January 2024. The price of Novolog and Novolog Mix 70/30 will be cut by 75%, with Novolin and Levemir seeing a 65% reduction in price. Novo’s cuts will take effect around the same time that the American Rescue Plan will be introduced.
Top 10 Journal Articles To Read During Your Infectious Diseases Pharmacy Rotation
IDStewardship
MARCH 12, 2023
In this post a top 10 list of journal articles to read during an infectious diseases pharmacy rotation is provided. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 12 March 2023 As a pharmacist serving as a preceptor to students and residents in the area of infectious diseases since 2010, I have always been on the hunt for good infectious diseases journal articles for my learners to read.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Why Congress should prioritize fixing the 340B program
PhRMA
MARCH 2, 2023
Nearly all Americans nationwide agree: Lowering out-of-pocket costs for health care should be a top priority for policymakers. Luckily, there are commonsense policies Congress could implement to meaningfully address the cost burdens Americans face. These include things like making sure patients aren’t paying more for their medicines than their health insurance company or requiring first-dollar coverage, so insurance companies cover the cost of certain lifesaving medicines from day one of the pla
FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion
Drug Topics
MARCH 7, 2023
The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Cleveland Clinic, IBM unveil first quantum computer dedicated to biomedical research
Fierce Healthcare
MARCH 21, 2023
Cleveland Clinic, IBM unveil first quantum computer dedicated to biomedical research hlandi Tue, 03/21/2023 - 11:49
Kite releases pivotal CAR T therapy Phase III study results
European Pharmaceutical Review
MARCH 21, 2023
Primary overall survival (OS) analysis results from Kite’s Phase III ZUMA-7 study showed a statistically significant improvement for CAR T-cell therapy Yescarta ® in OS versus historical treatment. Yescarta demonstrated a 2.5-fold increase in patients who were alive at two years and did not experience cancer progression or require the need for additional cancer treatment compared to standard of care (SOC).
Partnering With Microbiology Laboratory To Bring Awareness To Antimicrobial Resistance
IDStewardship
MARCH 23, 2023
In this article three infectious diseases pharmacists discuss the cross-roads of antimicrobial resistance and microbiology laboratory, reflecting on a recent Twitter chat on the topic. Patrick McDaneld, PharmD, BCIDP, Medical Science Liaison, Clinical Infectious Diseases, bioMérieux Brian Raux, PharmD, BCIDP, Medical Science Liaison, Clinical Infectious Diseases, bioMérieux Katherine Perez, PharmD, BCPS-AQ ID, Director, Antimicrobial Stewardship, bioMérieux Article Posted 24 March 2023 Active co
IRA Impacts: Cancer treatment research and development
PhRMA
MARCH 23, 2023
Last month marked the one-year anniversary of the reignited Cancer Moonshot, the White House’s ambitious goal of reducing the death rate from cancer by at least 50% over the next 25 years. Much of the positive trends in declining cancer mortality, down 33% since peaking in 1991, is driven in large part by innovative medicines researched and developed by America’s biopharmaceutical companies.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Ohio Attorney General Sues Express Scripts and Prime Therapeutics For Price Fixing
Drug Topics
MARCH 30, 2023
The suit alleges that Express Scripts, Prime and Prime customer Humana Pharmacy Solutions are able to share drug pricing and rebate information to increase prices for insulins, biologics and cancer drugs.
Opinion: There is no epidemic of autism. It’s an epidemic of need
STAT
MARCH 23, 2023
On Thursday, the Centers for Disease Control and Prevention announced another increase in the prevalence of autism among children. In a pair of new reports — one focused on 8-year-olds and one on 4-year-olds — the CDC found that 1 out of every 36 children has autism. This is a significant increase from the 2021 estimate of 1 in 44 , which was a big jump from 1 in 110 in 2006.
Here are the 20 highest paid specialties in 2022 as average physician pay drops 2.4%: Doximity
Fierce Healthcare
MARCH 23, 2023
Here are the 20 highest paid specialties in 2022 as average physician pay drops 2.
First nasal monoclonal antibody COVID-19 treatment shows potential
European Pharmaceutical Review
MARCH 9, 2023
A pilot study has demonstrated that a nasal version of the drug Foralumab, an anti-CD3 monoclonal antibody suppressed the inflammatory T cell response and decreased lung inflammation in patients with COVID-19. “This is the first nasal monoclonal antibody—other monoclonal antibody treatments were delivered intravenously and are no longer given as treatment because they are not effective against currently circulating viral variants,” explained Dr Howard Weiner, founder and Director of the Brigham
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pfizer, Viatris and more must face 'overarching conspiracy' claims in generic price-fixing suit
Fierce Pharma
MARCH 1, 2023
Pfizer, Viatris and more must face 'overarching conspiracy' claims in generic price-fixing suit aliu Wed, 03/01/2023 - 10:03
Key Trends: Patient experience data reveal how insurers and middlemen impose barriers in health care
PhRMA
MARCH 29, 2023
The Patient Experience Survey (PES) series continues to reveal how health insurance is not working as it should for too many Americans — especially vulnerable groups. This series – including surveys of 5,000 Americans conducted with Ipsos, a leading research company in the United States — documents a consistent trend in reports of insurer- and middlemen-imposed practices that can keep patients from the medicines and treatments that they need.
Treatment For Rare Immunodeficiency Disease Gets FDA Approval
Drug Topics
MARCH 27, 2023
The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.
Opinion: I finally got used to practicing telepsychiatry. Now the DEA wants to change everything
STAT
MARCH 24, 2023
I am by no means telepsychiatry’s biggest fan. But since March 2020, when my practice of outpatient psychiatry changed overnight, I have adapted to it. I have learned to get up between appointments so I don’t sit in front of a computer all day and how to fit in patient visits while on a work trip. I still prefer being in the actual room with a patient, but I accept this is the way my job looks now.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
CMS to raise Medicare Advantage pay rates by 3.3% in 2024; phase in risk adjustment changes
Fierce Healthcare
MARCH 31, 2023
CMS to raise Medicare Advantage pay rates by 3.
New NHS cell and gene therapy centre opens
European Pharmaceutical Review
MARCH 10, 2023
Today marks the opening the NHS Blood and Transplant (NHSBT)’s new Clinical Biotechnology Centre (CBC) in Bristol. The state-of-the-art facility was part-funded by a £9.43 million Government grant and is designed to expand the UK’s ability to manufacture new gene and cell therapies. The CBC will help the UK grow its cell and gene therapy industry in a rapidly growing international market.” “The CBC will help the UK grow its cell and gene therapy industry in a rapidly growing international
AbbVie's blockbuster-to-be Parkinson's combo hits a wall as FDA questions delivery pump
Fierce Pharma
MARCH 22, 2023
AbbVie's blockbuster-to-be Parkinson's combo hits a wall as FDA questions delivery pump aliu Wed, 03/22/2023 - 11:17
PhRMA provides comments and testimony to USITC investigation on COVID-19 medicines and the TRIPS Agreement
PhRMA
MARCH 30, 2023
At the request of the U.S. Trade Representative, the U.S. International Trade Commission (USITC) is conducting an investigation and will issue an accompanying report concerning the TRIPS Agreement and a variety of issues related to COVID-19 diagnostics and therapeutics. According to USTR, the USITC report will inform future discussions within the United States and at the World Trade Organization (WTO) concerning potential TRIPS waiver expansion.
PBM Transparency Bill Heads to Full Senate
Drug Topics
MARCH 23, 2023
The proposed legislation, sponsored by Chuck Grassley and Maria Cantwell, aims to necessitate transparency from PBMs.
Cases of Marburg going unreported in Equatorial Guinea, WHO says
STAT
MARCH 29, 2023
The Marburg outbreak in Equatorial Guinea continues to grow, the World Health Organization said Wednesday, as the global health agency stated that it knows of confirmed cases that the country has not yet reported. To date Equatorial Guinea has acknowledged nine laboratory-confirmed cases, seven of whom have died. In addition, 20 other people with links to the confirmed cases died without being tested; they are considered probable cases.
Uber Health rolls out same-day prescription delivery with plans to ship healthy food, OTC meds
Fierce Healthcare
MARCH 30, 2023
Uber Health rolls out same-day prescription delivery with plans to ship healthy food, OTC meds hlandi Thu, 03/30/2023 - 12:54
Mass spectrometry software can link different data types
European Pharmaceutical Review
MARCH 15, 2023
The latest version of software tool MZmine, which aids analysis of mass spectrometry data, has been released. Using this third generation software, scientists can analyse large volumes of data from mass spectrometry, processing thousands of samples within minutes to hours. [the newest version can process] thousands of samples within minutes to hours.” It is the first tool with an entire data processing pipeline that integrates liquid chromatography (LC)-ion mobility spectrometry (IMS)-MS a
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
MARCH 27, 2023
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries esagonowsky Mon, 03/27/2023 - 09:19
Insurer and PBM tactics are shifting higher costs to patients with chronic and complex conditions
PhRMA
MARCH 2, 2023
Health plans are increasingly using deductibles and coinsurance to shift more of the cost of care to chronically ill patients taking brand medicines. As data from IQVIA show, this alarming trend is especially burdensome for patients with cancer, who pay nearly 10X more on average per year for their medicines when they face deductibles and coinsurance versus patients with only fixed copays.
Using Data Analytics to Manage Pharmacy Inventory
Drug Topics
MARCH 23, 2023
Crunching the numbers can help pharmacies stay on top of their inventory.
Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
STAT
MARCH 13, 2023
An algorithm, not a doctor, predicted a rapid recovery for Frances Walter, an 85-year-old Wisconsin woman with a shattered left shoulder and an allergy to pain medicine. In 16.6 days, it estimated, she would be ready to leave her nursing home. On the 17th day, her Medicare Advantage insurer, Security Health Plan, followed the algorithm and cut off payment for her care, concluding she was ready to return to the apartment where she lived alone.
Taxpayers shouldn't foot the bill for health systems' massive 2022 investment losses, health economists say
Fierce Healthcare
MARCH 23, 2023
Taxpayers shouldn't foot the bill for health systems' massive 2022 investment losses, health economists say dmuoio Thu, 03/23/2023 - 17:25
Identifying origin of fungi in cleanrooms
European Pharmaceutical Review
MARCH 22, 2023
In a recent video , pharmaceutical microbiology expert Tim Sandle highlighted areas of concern and attention relating to mycological contamination control in manufacturing. Pharmaceutical product recalls due to fungal contamination have been increasing. These, together with environmental monitoring trend data, highlight several fungal contamination issues associated with pharmaceutical cleanrooms , cold rooms and other controlled areas.
Lilly cuts insulin prices, caps out-of-pocket costs
Drug Store News
MARCH 3, 2023
Lilly also will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin.
Let's personalize your content